S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates
S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates
S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates
S&P 500   5,199.06
DOW   38,459.08
QQQ   445.37
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024
Stock market today: Global markets mixed after Wall St rebound led by Big Tech
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
How major US stock indexes fared Thursday, 4/11/2024
Closing prices for crude oil, gold and other commodities
Carmax Returns to the Bargain Basement: Buy the Dip? 
Homebuyers’ quandary: to wait or not to wait for lower mortgage rates

The Cigna Group (CI) Competitors

$353.08
-4.76 (-1.33%)
(As of 04/11/2024 ET)

CI vs. ELV, CNC, HUM, UNH, VRTX, BMY, REGN, MDT, BSX, and SNY

Should you be buying The Cigna Group stock or one of its competitors? The main competitors of The Cigna Group include Elevance Health (ELV), Centene (CNC), Humana (HUM), UnitedHealth Group (UNH), Vertex Pharmaceuticals (VRTX), Bristol-Myers Squibb (BMY), Regeneron Pharmaceuticals (REGN), Medtronic (MDT), Boston Scientific (BSX), and Sanofi (SNY). These companies are all part of the "medical" sector.

The Cigna Group vs.

The Cigna Group (NYSE:CI) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, community ranking, institutional ownership, earnings, profitability and risk.

In the previous week, Elevance Health had 4 more articles in the media than The Cigna Group. MarketBeat recorded 21 mentions for Elevance Health and 17 mentions for The Cigna Group. Elevance Health's average media sentiment score of 0.78 beat The Cigna Group's score of 0.50 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Cigna Group
7 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Elevance Health
9 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

The Cigna Group pays an annual dividend of $5.60 per share and has a dividend yield of 1.6%. Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.3%. The Cigna Group pays out 32.2% of its earnings in the form of a dividend. Elevance Health pays out 25.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

The Cigna Group received 102 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 71.82% of users gave The Cigna Group an outperform vote while only 66.42% of users gave Elevance Health an outperform vote.

CompanyUnderperformOutperform
The Cigna GroupOutperform Votes
925
71.82%
Underperform Votes
363
28.18%
Elevance HealthOutperform Votes
823
66.42%
Underperform Votes
416
33.58%

Elevance Health has a net margin of 3.49% compared to The Cigna Group's net margin of 2.64%. Elevance Health's return on equity of 20.47% beat The Cigna Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Cigna Group2.64% 13.59% 4.12%
Elevance Health 3.49%20.47%7.19%

87.0% of The Cigna Group shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 0.7% of The Cigna Group shares are held by insiders. Comparatively, 0.3% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Elevance Health has lower revenue, but higher earnings than The Cigna Group. Elevance Health is trading at a lower price-to-earnings ratio than The Cigna Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Cigna Group$195.19B0.53$5.16B$17.3920.30
Elevance Health$171.34B0.68$5.99B$25.1719.94

The Cigna Group has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500.

The Cigna Group presently has a consensus price target of $362.14, indicating a potential upside of 2.57%. Elevance Health has a consensus price target of $569.00, indicating a potential upside of 13.36%. Given Elevance Health's higher probable upside, analysts clearly believe Elevance Health is more favorable than The Cigna Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Cigna Group
0 Sell rating(s)
2 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.92
Elevance Health
0 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.90

Summary

Elevance Health beats The Cigna Group on 12 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CI vs. The Competition

MetricThe Cigna GroupHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$103.22B$60.97B$5.04B$17.47B
Dividend Yield1.54%1.40%2.96%3.47%
P/E Ratio20.3018.27271.1625.59
Price / Sales0.530.482,379.1310.91
Price / Cash9.9910.1535.6417.89
Price / Book2.233.324.695.17
Net Income$5.16B$3.04B$104.33M$971.52M
7 Day Performance-1.94%0.07%-0.72%-0.70%
1 Month Performance3.16%-8.31%-0.84%0.34%
1 Year Performance32.50%-1.96%19.05%116.18%

The Cigna Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELV
Elevance Health
4.1948 of 5 stars
$499.22
-3.3%
$569.36
+14.1%
+2.5%$116.17B$171.34B19.83104,900Upcoming Earnings
Analyst Report
Short Interest ↓
CNC
Centene
4.8479 of 5 stars
$72.43
-6.8%
$85.46
+18.0%
+6.4%$38.74B$154.00B14.7567,700Short Interest ↓
HUM
Humana
4.9992 of 5 stars
$304.33
-13.4%
$494.00
+62.3%
-40.7%$36.72B$106.37B15.3567,600Analyst Report
High Trading Volume
UNH
UnitedHealth Group
4.996 of 5 stars
$458.16
-6.4%
$579.33
+26.4%
-15.2%$422.39B$371.62B19.22440,000Upcoming Earnings
Analyst Report
High Trading Volume
VRTX
Vertex Pharmaceuticals
4.3699 of 5 stars
$409.42
-2.6%
$420.48
+2.7%
+23.2%$105.76B$9.87B29.485,400Analyst Report
News Coverage
BMY
Bristol-Myers Squibb
4.6145 of 5 stars
$52.75
-0.5%
$61.12
+15.9%
-29.9%$106.91B$45.01B13.6734,100Short Interest ↓
Analyst Revision
REGN
Regeneron Pharmaceuticals
3.8429 of 5 stars
$954.68
-1.5%
$968.43
+1.4%
+12.3%$104.79B$13.12B27.4713,450Analyst Report
News Coverage
MDT
Medtronic
4.6013 of 5 stars
$85.20
-2.1%
$94.91
+11.4%
+1.4%$113.13B$31.23B27.1395,000Positive News
BSX
Boston Scientific
4.2521 of 5 stars
$67.47
-0.9%
$66.62
-1.3%
+35.7%$99.17B$14.24B63.0648,000Short Interest ↑
SNY
Sanofi
3.0956 of 5 stars
$47.70
-1.2%
$55.00
+15.3%
-15.6%$120.66B$46.61B20.2186,088Positive News

Related Companies and Tools

This page (NYSE:CI) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners